Tetraphase Pharmaceuticals, Inc.
TTPH
TTPH was delisted on the 28th of July, 2020.
26 hedge funds and large institutions have $5.69M invested in Tetraphase Pharmaceuticals, Inc. in 2020 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 4 closing their positions.
45% more capital invested
Capital invested by funds: $3.93M → $5.69M (+$1.76M)
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
4% more funds holding
Funds holding: 25 → 26 (+1)
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
+$148K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$55.3K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$42.4K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$19K |
| 5 |
JP Morgan Chase
New York
|
+$9.61K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$854K |
| 2 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$320K |
| 3 |
Renaissance Technologies
New York
|
-$39.4K |
| 4 |
BlackRock
New York
|
-$28.6K |
| 5 |
Bank of New York Mellon
New York
|
-$9.54K |
TTPH Hedge Fund Activity: Q2 2020 in Review
26 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in Tetraphase Pharmaceuticals, Inc. (TTPH) for Q2 2020, worth a combined $5.69M — up 45% from $3.93M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new TTPH positions and 4 closed out — a net gain of 1 holder — while 4 added to existing stakes and 6 trimmed.
The largest buyer was Acadian Asset Management, opening a new position worth an estimated $148K. The largest seller was Sabby Management, exiting entirely with an estimated $854K sold.
- 26 institutional investors held Tetraphase Pharmaceuticals, Inc. (TTPH) as of Q2 2020, up from 25 in Q1 2020.
- Funds reported $5.69M of Tetraphase Pharmaceuticals, Inc. stock for Q2 2020, up 45% quarter-over-quarter.
- 5 funds opened new Tetraphase Pharmaceuticals, Inc. positions in Q2 2020 and 4 closed out, a net change of +1 holder.
- The largest Tetraphase Pharmaceuticals, Inc. buyer in Q2 2020 was Acadian Asset Management, an estimated $148K added.
- The largest Tetraphase Pharmaceuticals, Inc. seller in Q2 2020 was Sabby Management, an estimated $854K sold.
Based on aggregated 13F filings for Q2 2020.